Supplementary Table 3.

Prevalence of transmembrane protease serine 2 and v-ets erythroblastosis virus E26 oncogene homolog fusion stratified by examined countries in Asia

Country	Pooled positive rate (%)	95% CI	Patient (n)
Korea	25	21–30	2323
China	25	17–34	1490
Japan	21	17–25	849
India	52	43–60	329
Philippines	23	-	104
Turkey	46	-	99
Malesia	13	-	8

CI: confidence interval